➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Moodys
Johnson and Johnson
Colorcon
McKesson
Harvard Business School

Last Updated: August 5, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR TRULICITY

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

All Clinical Trials for TRULICITY

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00734474 ↗ A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin Completed Berry Consultants Phase 2/Phase 3 2008-08-01 This is an adaptive dose finding study and a Phase 3 efficacy study to evaluate the effects of once weekly injection of LY2189265 compared to Sitagliptin on glucose by measuring glycosylated hemoglobin (HbA1c) change from baseline after 52 weeks in participants with type 2 diabetes mellitus on Metformin.
NCT00734474 ↗ A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin Completed Tessella Inc. Phase 2/Phase 3 2008-08-01 This is an adaptive dose finding study and a Phase 3 efficacy study to evaluate the effects of once weekly injection of LY2189265 compared to Sitagliptin on glucose by measuring glycosylated hemoglobin (HbA1c) change from baseline after 52 weeks in participants with type 2 diabetes mellitus on Metformin.
NCT00734474 ↗ A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin Completed United BioSource Corporation Phase 2/Phase 3 2008-08-01 This is an adaptive dose finding study and a Phase 3 efficacy study to evaluate the effects of once weekly injection of LY2189265 compared to Sitagliptin on glucose by measuring glycosylated hemoglobin (HbA1c) change from baseline after 52 weeks in participants with type 2 diabetes mellitus on Metformin.
NCT00734474 ↗ A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin Completed Eli Lilly and Company Phase 2/Phase 3 2008-08-01 This is an adaptive dose finding study and a Phase 3 efficacy study to evaluate the effects of once weekly injection of LY2189265 compared to Sitagliptin on glucose by measuring glycosylated hemoglobin (HbA1c) change from baseline after 52 weeks in participants with type 2 diabetes mellitus on Metformin.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for TRULICITY

Condition Name

Condition Name for TRULICITY
Intervention Trials
Diabetes Mellitus, Type 2 4
NASH - Nonalcoholic Steatohepatitis 1
Weight Change, Body 1
Glucose Intolerance 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for TRULICITY
Intervention Trials
Diabetes Mellitus, Type 2 5
Diabetes Mellitus 5
Polydipsia 1
Glucose Intolerance 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for TRULICITY

Trials by Country

Trials by Country for TRULICITY
Location Trials
United States 51
Canada 5
Mexico 2
Romania 2
Switzerland 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for TRULICITY
Location Trials
Georgia 3
Texas 3
Maryland 2
Missouri 2
Nevada 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for TRULICITY

Clinical Trial Phase

Clinical Trial Phase for TRULICITY
Clinical Trial Phase Trials
Phase 4 5
Phase 3 1
Phase 2/Phase 3 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for TRULICITY
Clinical Trial Phase Trials
Recruiting 5
Not yet recruiting 3
Completed 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for TRULICITY

Sponsor Name

Sponsor Name for TRULICITY
Sponsor Trials
Eli Lilly and Company 3
University Hospital, Basel, Switzerland 2
United BioSource Corporation 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for TRULICITY
Sponsor Trials
Other 7
Industry 6
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Boehringer Ingelheim
Express Scripts
Medtronic
McKinsey
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.